News & Analysis on Pharmaceutical Technology & Manufacturing
Bayer, Marianne De Backer
By Ben Hargreaves
- Last updated on
Bayer announces that Marianne De Backer will join the company as its new head of business development & licensing of its Pharmaceuticals division. In addition, De Backer will become a member of the executive committee.
Regarding her remit in the position, Stefan Oelrich, president of the company's Pharmaceuticals division, said, "[De Backer’s] breadth of experience in successfully forming and managing external alliances will be one of the key drivers for Bayer's continued growth, ultimately aimed at providing new medicines and solutions to patients."
De Backer joins Bayer from Johnson & Johnson, where she led M&A operations and divestitures for the pharmaceutical group.
As well as working at Bayer, she will retain her role as a member of the board of directors at EcoHealth Alliance, the same position at Gladstone Foundation, and as a member of the advisory board at Biocom.